Introduction
As average longevity increases, neurodegenerative diseases become more prevalent and problematic, especially as treatments for these diseases are unavailable or ineffective. In many cases, the identity of genes that predispose or cause neurodegenerative disease is clear: huntingtin in Huntington's disease, β-amyloid and tau in Alzheimer's disease, and α-synuclein in Parkinson's disease. While these discoveries have led to improvements in diagnosis, the molecular mechanisms underlying neurodegeneration remain poorly understood. Many neurodegenerative disease genes are broadly expressed throughout the body, yet, in many cases, specific neural tissues are affected which suggests neuron-specific roles for disease proteins. In addition, a hallmark of many age-associated neurodegenerative disorders is aberrant accumulation or aggregation of the 
